GNH USA

Europe — EMA

Novorapid Pumpcart (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Pumpcart, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It manages blood glucose levels in people with diabetes mellitus.

Request sourcing

1
Pack/s

What is Insulin Aspart?

Insulin aspart, the active ingredient in Novorapid Pumpcart, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It manages blood glucose levels in people with diabetes mellitus. GNH USA supplies Novorapid Pumpcart as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorapid Pumpcart as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Insulin Aspart used for?

Novorapid Pumpcart is a rapid-acting insulin analog that works on the carbohydrate‑carbo­diol metabolic pathway and the t  ​  ​  ​   ​  ​  ​  ​   ​  ​    ​    ​   ​   ​   ​   ​  ​  ​    ​  ​    ​      ​ ​  ​  ​  ​  ​

- Type 1 Diabetes Mellitus: Helps to control post‑meal blood glucose levels. - Diabetes Type 2 with insulin requirement : Provides rapid glycemic control of the after‑effects of  ​   -   -   -  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Insulin Aspart
Route
Subcutaneous Use
Manufacturer
Novo Nordisk A/S
Origin
EU

Related products